Explant rates of electrical neuromodulation devices in 1177 patients in a single center over an 11-year period
A Al-Kaisy, J Royds, O Al-Kaisy, S Palmisani… - Regional Anesthesia & …, 2020 - rapm.bmj.com
Introduction The publication of explant rates has established risk factors and a definitive
objective outcome of failure for spinal cord stimulation (SCS) treating neuropathic pain. We …
objective outcome of failure for spinal cord stimulation (SCS) treating neuropathic pain. We …
[BOOK][B] STEADY AND PULSATILE FLOW ANALYSIS IN A MODEL OF THE HUMAN AORTIC ARCH.
TL Yearwood - 1979 - search.proquest.com
Reproduced with permission of the copyright owner. Further reproduction prohibited without
permission. Page 1 Reproduced with permission of the copyright owner. Further reproduction …
permission. Page 1 Reproduced with permission of the copyright owner. Further reproduction …
Explant rates of neuromodulation devices: supplemental information—reply to Mukhdomi and Harris
A Al-Kaisy, J Royds, O Al-Kaisy… - … and Pain Medicine, 2021 - search.proquest.com
infection following medical device implantation appears to occur for a prolonged period as
highlighted by our study. 2 We have compared our explant rate due to infection to other …
highlighted by our study. 2 We have compared our explant rate due to infection to other …